Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment
Emcure Pharmaceuticals Ltd announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for the...
OneSource Partners with Germany’s Formycon AG to Produce Biosimilars for Global Markets
OneSource Speciality Pharma has entered into a strategic manufacturing partnership with Germany’s Formycon AG to produce biosimilar medicines for global markets, reinforcing India's growing role as...
QDENGA: A Milestone in India’s Battle Against Dengue
The onset of monsoon in India apart from bringing relief from the sweltering heat marks the rise of dengue cases. Every year, lakhs of people infected by...
Medtronic MEIC Expands Breast and Cervical Cancer Screenings in Hyderabad
The Medtronic Engineering and Innovation Center (MEIC) in Hyderabad has initiated a series of health and development initiatives aimed at uplifting underserved local communities.
Driven by Medtronic’s core mission...
Lupin Introduces Kaveri Therapeutics to Accelerate Cancer Drug Development
Lupin Limited announced the strategic spin-out of two promising oncology assets LNP7457 (PRMT5) and LNP8701 (SOS1) into Kaveri Therapeutics Inc. , a U.S.-based, clinical-stage oncology company dedicated to advancing targeted...
NATCO Gets USFDA Nod for Generic Cancer Drug Olaparib
Alembic Pharmaceuticals Limited announced that its development partner, NATCO Pharma Limited (NATCO), has received tentative approval from the U.S. Food and Drug Administration (USFDA)...